Ultragenyx Pharma (RARE) PT Raised to $90 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Ultragenyx Pharma (RARE) PT Raised to $59 at Morgan Stanley
August 7, 2018 7:14 AM EDTMorgan Stanley raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $59.00 (from $57.00) while maintaining a Equalweight rating.
... MoreUltragenyx Pharma (RARE) PT Raised to $80 at Wedbush
August 6, 2018 7:50 AM EDTWedbush raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $80.00 (from $71.00) while maintaining a Outperform rating.
... MoreUltragenyx Pharma (RARE) PT Raised to $85 at Piper Jaffray
August 3, 2018 6:01 AM EDTPiper Jaffray raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $85.00 (from $67.00) while maintaining a Overweight rating.
... MoreUltragenyx Pharma (RARE) PT Raised to $92 at Barclays
August 3, 2018 5:15 AM EDTBarclays raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $92.00 (from $74.00) while maintaining a Overweight rating.
... MoreUltragenyx Pharma (RARE) Posts Smaller-than-Expected Q2 Loss
August 2, 2018 5:06 PM EDTUltragenyx Pharma (NASDAQ: RARE) reported Q2 EPS of ($1.06), $1.03 better than the analyst estimate of ($2.09). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $5.42 million.
For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.
... More